DarioHealth (NASDAQ:DRIO) Director Acquires $99,999.90 in Stock

DarioHealth Corp. (NASDAQ:DRIO) Director Dennis Matheis acquired 14,430 shares of the company’s stock in a transaction on Thursday, July 23rd. The stock was purchased at an average cost of $6.93 per share, for a total transaction of $99,999.90. Following the completion of the purchase, the director directly owned 43,026 shares in the company, valued at $298,170.18. This trade represents a 50.46% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

DarioHealth Stock Up 1.4%

Shares of DarioHealth stock opened at $7.20 on Friday. DarioHealth Corp. has a one year low of $5.84 and a one year high of $17.74. The company has a market cap of $52.85 million, a P/E ratio of -0.81 and a beta of 1.09. The company has a debt-to-equity ratio of 0.50, a quick ratio of 2.62 and a current ratio of 3.07. The firm has a fifty day moving average of $7.15 and a two-hundred day moving average of $8.56.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on DRIO shares. Stifel Nicolaus reaffirmed a “buy” rating and issued a $10.00 price objective on shares of DarioHealth in a report on Thursday, May 14th. Weiss Ratings reissued a “sell (e+)” rating on shares of DarioHealth in a report on Friday, July 10th. Finally, TD Cowen restated a “hold” rating and issued a $11.00 price target on shares of DarioHealth in a research note on Wednesday, May 13th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, DarioHealth currently has an average rating of “Hold” and a consensus target price of $10.50.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Geode Capital Management LLC boosted its stake in shares of DarioHealth by 167.9% during the 4th quarter. Geode Capital Management LLC now owns 49,567 shares of the company’s stock worth $564,000 after acquiring an additional 31,063 shares in the last quarter. XTX Topco Ltd raised its holdings in DarioHealth by 229.0% during the second quarter. XTX Topco Ltd now owns 62,511 shares of the company’s stock worth $42,000 after purchasing an additional 43,513 shares during the last quarter. Finally, Kestra Advisory Services LLC acquired a new position in DarioHealth during the fourth quarter worth $35,000. 33.39% of the stock is owned by hedge funds and other institutional investors.

DarioHealth Company Profile

DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes.

The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education.